Bausch + Lomb Buys Novartis Drugs for $1.75 Billion Expanding Eye Care Portfolio
Eye care company Bausch + Lomb said it would pay $1.75 billion to acquire a portfolio of eye care products from Swiss healthcare giant Novartis.
( 1
min )